Abstract
Combined antiretroviral therapy (CART) has turned HIV-infection to a treatable chronic disease during which many patients survive to middle and older age. However, they prematurely develop non-AIDS comorbidities such as cardiovascular disease, metabolic syndrome, diabetes, and HIV-associated neurocognitive disorders (HAND). Microcirculatory changes and endothelial dysfunction occur early both in HIV-infected and in aging patients, in whom they usually precede cardiovascular and neurocognitive impairments. Also, mild cognitive involvement has been reported in women during the menopausal transition. Disruption of the blood-brain barrier, as well as microvascular and cerebral blood flow changes, has been reported in HIV patients with HAND, including postmenopausal women. However, most studies addressing this issue included women aged less than 50 years. Whether HIV-infected women growing older with CART would be subsequently exposed to an increased progression of cognitive impairment overtime remains unknown.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
van Sighem AI, Gras JA, Reiss P, Brinkman K, de Wolf F. Life-expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. AIDS. 2010;24:1527–35.
Monsuez JJ, Charniot JC, Escaut L, et al. HIV-associated vascular disease: structural and functional changes, clinical implications. Int J Cardiol. 2009;133(3):293–306.
Borges JP, Tibirica E, Soares PP, et al. Assessment of vascular function in HIV-infected patients. HIV Clin Trials. 2011;12(4):216–21.
Nightingale S, Winsto A, Letendre S, et al. Controversies in HIV-associated neurocognitive disorders. Lancet Neurol. 2014;13(11):1139–51.
Palios J, Ikonomidis J, Lekakis J, et al. Microcirculatory vascular dysfunction in HIV-1 infected patients receiving highly active antiretroviral therapy. Microcirculation. 2010;4:303–10.
Bladowska J, Knysz B, Zimny A, et al. Value of perfusion-weighted MR imaging in the assessment of early cerebral alterations in neurologically asymptomatic HIV-1 positive and HCV positive patients. PLoS ONE. 2014;9(7):e102214.
Kanapathipillai R, Hickey M, Giles M. Human immunodeficiency virus and menopause. Menopause. 2013;9:983–90.
Miller SA, Santoro N, Lo Y, et al. Menopause symptoms in HIV-infected and drug-using women. Menopause. 2005;3:348–56.
Alcaide ML, Parmigiani A, Pallikuth S, et al. Immune activation in HIV-infected aging women on antiretrovirals—implications for age-associated comorbidities: a cross-sectional pilot study. PLoS ONE. 2013;8(5):e53804.
Rubin LH, Sundermann EE, Cook JA, et al. An investigation of menopausal stage and symptoms on cognition in HIV-infected women. Menopause. 2014;9:997–1006.
Maki P, Rubin LH, Valcour V, Martin E, Crystal H, Young M, et al. Cognitive function in women with HIV. Neurology. 2015;84:231–40. The Women’s Interagency HIV Study is the largest cohort study of neuropsychological outcomes among HIV-infected women.The 1521 included women (1019 HIV-infected) completed a comprehensive neuropsychological test battery repeated during follow up and correlated to HIV status.
Monsuez JJ, Dufaux J, Vittecoq D, Vicaut E. Hemorheology in asymptomatic HIV-infected patients. Clin Hemorheol. 2000;23:59–66.
Athanassiou GA, Moutzouri AG, Gogos CA, Skoutelis AT. Red blood cell deformability in patients with immunodeficiency virus infection. Eur J Clin Microbiol Infect Dis. 2010;7:845–9.
Monsuez JJ, Vittecoq D, Dufaux J, Vicaut E. Reduced reactive hyperemia in HIV-infected patients. JAIDS. 2000;24:434–42.
Maggi P, Bellacosa C, Grattagliano V, Pastore G, Lapadula G. Functional impairments of microcirculation in HIV-positive patients: a laser Doppler fluxometry-based investigation. HIV Clin Trials. 2008;6:428–33.
Wang D, Melancon JK, Verbesey J, et al. Microvascular endothelial dysfunction and enhanced thromboxane and endothelial contractility in patients with HIV. J AIDS Clin Res. 2014;4:267. doi:10.4172/2155-6113.1000267.
Van Wijk JP, de Koning EJ, Cabezas MC, et al. Functional and structural markers of atherosclerosis in human immunodeficiency virus-infected patients. J Am Coll Cardiol. 2006;47:1117–23.
Torriani FJ, Komarow L, Parker RA, et al. Endothelial dysfunction in human immunodeficiency virus-infected antiretroviral naive subjects before and after starting potent antiretroviral therapy. J Am Coll Cardiol. 2008;52:569–76.
Sharma B. Oxidative stress in HIV patients receiving antiretroviral therapy. Curr HIV Res. 2014;12(1):13–21.
Kraft-Terry S, Gerena Y, Wojna V, et al. proteomic analyses of monocytes obtained from Hispanic women with HIV-associated dementia show depressed antioxidants. Proteomics Clin Appl. 2010;8:706–14.
Bentov I, Reed MJ. The effect of aging on the cutaneous microvasculature. Microvasc Res. 2015;100:25–31.
LeBlanc AJ, Hoying JB. Adaptation of the coronary microcirculation in aging. Microcirculation. 2016;2:157–67.
Brown WR, Thore CR. Cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol. 2011;37:56–74.
Muller-Delp JM, Gurovich AN, Christou DD, Leeuwenburgh C. Redox balance in the aging microcirculation: new friends, new foes, and new clinical directions. Microcirculation. 2012;1:19–26.
Fujii N, Meade RD, Alexander LM, et al. iNOS-dependent sweating and eNOS-dependent cutaneous vasodilation are evident in younger adults, but are diminished in older adults exercising in the heat. J Appl Physiol. 2016;120(3):318–27.
Ogrin R, Darzins P, Khalil Z. Age-related changes in microvascular blood flow and transcutaneous oxygen tension under basal and stimulated conditions. J Gerontol A Biol Sci Med Sci. 2005;60(2):200–6.
Chantier PD, Shrader CD, Tabone LF, et al. Cerebral cortical microvascular rarefaction in metabolic syndrome is dependent on insulin resistance and loss of nitric oxide bioavailability. Microcirculation. 2015;6:435–45.
Walther G, Obert P, Dutheil F, et al. Metabolic syndrome individuals with and without type 2 diabetes mellitus present generalized vascular dysfunction: cross sectional study. Arterioscler Thromb Vasc Biol. 2015;35:1022–9.
Nix LM, Tien PC. Metabolic syndrome, diabetes, and cardiovascular risk in HIV. Curr HIV/AIDS Rep. 2014;11:275–8.
Gerena Y, Skolasky RL, Velez JM, et al. Soluble and cell-associated insulin receptor dysfunction correlates with severity of HAND in HIV-infected women. PLoS ONE. 2012;7(5):e37358. This article shows the relationship between HIV-induced metabolic syndrome, insulin resistance, and HIV-associated cognitive impairment. Evidence is shown that: 1 insulin receptor secretion is increased in HIV-infected women; 2 increased insulin receptor secretion is associated with cognitive impairment in these women.
Wu DT, Woodman SE, Weiss JM, et al. Mechanisms of leukocyte trafficking into the CNS. J Neurovirol. 2000;6:582–5.
Takahashi K, Wessellingh SL, Griffin DE, McArthur JC, Johnson RT, Glass JD. Localization of HIV-1 in human brain using polymerase chain reaction in situ hybridization and immunocytochemistry. Ann Neurol. 1996;39:705–11.
Strazza M, Pirrone V, Wigahl B, Nonemacher MR. Breaking down the barrier: the effect of HIV-1 on the blood-brain barrier. Brain Res. 2011;1399:96–115.
Xu R, Feng X, **e X, Zhang J, Wu D, Xu L, et al. HIV-1 Tat protein increases the permeability of brain endothelial cells by both inhibiting occluding expression and cleaving occluding via matrix metalloproteinase-9. Brain Res. 2012;1436:13–9.
Toborek M, Lee YW, Pu H, et al. HIV-Tat protein induces oxidative and inflammatory pathways in brain circulation. J Neurochem. 2003;84:109–79.
Towgood KJ, Pikanen M, Kulasegaram R, et al. regional cerebral blood flow and FDG uptake to asymptomatic HIV-1 men. Human Brain Mapp. 2013;34:2484–93.
Ances BM, Valda F, Cherner M, et al. HIV and chronic metamphetamine dependence affect cerebral blood flow. J Neuroimmune Pharmacol. 2011;6:409–19.
Ances BM, Valda F, Yeh MJ, et al. HIV infection and aging independently affect brain function as measured by functional resonance imaging. J Infect Dis. 2010;201:336–40.
Silva JN, Polesskaia O, Wei HS, et al. Chronic central nervous system expression of HIV-1 Tat leads to accelerated rarefaction of neocortical capillaries and loss of red blood cell velocity heterogeneity. Microcirculation. 2014;7:664–76. In this animal study, the authors show that HIV-1 protein Tat accelerates cerebral microvascular rarefaction and reduces cerebral microvascular blood flow.
Airaldi M, Bandera A, Trabattoni D, et al. Neurocognitive impairment in HIV-infected naïve patients with advanced disease: the role of virus and intrathecal immune activation. Clin Dev Immunol. 2012. doi:10.1155/2012/467154.
Elbirt D, Mahlab-Guri K, Bezalel-Rosenberg S, Gill H, Attali M, Asher I. HIV-associated neurocognitive disorders (HAND). IMAJ. 2015;17:54–9.
Lindl KA, Marks DR, Kolson DL, Jordan-Schiutto KL. HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities. J Neuroimmune Pharmacol. 2010;5:294–309.
Gustafson DR, Mielke MM, Tien PC, et al. Anthropometric measures and cognition in middle-aged HIV-infected and uninfected women. The Women’s Interagency HIV study. J Neurovirol. 2013;6:574–85.
Valcour V, Maki P, Bacchetti P, et al. Insulin resistance and cognition among HIV-infected and HIV-uninfected adult women: the Women’s Interagency HIV study. AIDS Res Human Retrovir. 2012;28(5):447–53.
Gerena Y, Menendez-Delmestre R, Skolasky RL, et al. Soluble insulin receptor as a source of insulin resistance and cognitive impairment in HIV-seropositive women. J Neurovirol. 2015;2:113–9.
Cysique LA, Moffat K, Moore DM, et al. HIV, vascular and aging injuries in the brain of clinically stable HIV-infected adults: a H MRS study. PLoS ONE. 2013;8:e61738.
Guaraldi G, Zona S, Alexopoulos N, et al. Coronary aging in HIV-infected patients. Clin Infect Dis. 2009;49:1756–62.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Olivier Bouchaud reports grants from GSK, MSD, Gilead, and ANRS; personal fees from BMS, MSD; non-financial support from Gilead and MSD.
Jean-Jacques Monsuez and Catherine Belin declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Behavioral-Bio-Medical Interface
Rights and permissions
About this article
Cite this article
Monsuez, JJ., Belin, C. & Bouchaud, O. Microvascular Function in Aging Among Women Living with HIV. Curr HIV/AIDS Rep 13, 392–398 (2016). https://doi.org/10.1007/s11904-016-0339-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11904-016-0339-3